Recursion Pharmaceuticals call volume above normal and directionally bullish
Bullish option flow detected in Recursion Pharmaceuticals (RXRX) with 7,493 calls trading, 2x expected, and implied vol increasing almost 4 points to 94.34%. Jan-25 6 calls and Jun-25 7 calls are the most active options, with total volume in those strikes near 4,100 contracts. The Put/Call Ratio is 0.04. Earnings are expected on February 27th.
Don't Miss our Black Friday Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See today’s best-performing stocks on TipRanks >>
Read More on RXRX:
- Recursion, Exscientia shareholders approve proposed combination
- Recursion Pharmaceuticals Reports Q3 2024 Earnings and Strategic Milestones
- Closing Bell Movers: AppLoving up 29% after Q3 earnings beat
- Recursion Pharmaceuticals reports Q3 EPS (34c), consensus (35c)
- Recursion Pharmaceuticals Advances Drug Discovery and Partnerships
TipRanks is the most comprehensive data set of sell side analysts and hedge fund managers. TipRanks' multi-award winning platform ranks financial experts based on measured performance and the accuracy of their predictions so investors know who to trust when making investment decisions.